Funds &Investors

It’s all about the money. Not. Surely, collecting and providing capital is at the heart of our business. But so is truly moving the market, with deep industry and operational expertise. With that in mind, we strive to achieve both: Growth for our portfolio companies and attractive returns for our investors. Our strong track record has been built over 20 years – with 53 deals, 21 exits and many potential highflyers in the portfolio.

In a healthcare VC investment landscape, which traditionally tends to be more reserved, Wellington Partners is proud to have established itself as one of the leading early- and growth-stage investors – attracting more than 600 investment proposals per year, and by returning investors such as the European Investment Fund and the European Investment Bank, as well as family offices, trusts, insurance companies and other financial institutions.

“Success is not measured in the amount of dollars you make, but the amount of lives you impact.”

— Anonymous

Life Science Funds

Here is an overview of our funds so far:

WPLS V

210m

EUR

Closing: 2017
Investments: 15

WPLS IV

85m

EUR

Closing: 2012
Investments: 14

WPLS III

78m

EUR

Closing: 2007
Investments: 13

WP II

(life science & tech fund)

35m

EUR for LS

Closing: 2000
Investments: 4 in LS

WP I

(life science & tech fund)

10m

EUR for LS

Closing: 1998
Investments: 9 in LS